| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Editorial Board & Publication Information
|
|
|
2011
|
21 |
4 |
p. CO2-
1 p.
|
artikel
|
| 2 |
Emerging importance of ALK in neuroblastoma
|
Azarova, Anna M.
|
|
2011
|
21 |
4 |
p. 267-275
9 p.
|
artikel
|
| 3 |
Genetically engineered murine models – Contribution to our understanding of the genetics, molecular pathology and therapeutic targeting of neuroblastoma
|
Chesler, Louis
|
|
2011
|
21 |
4 |
p. 245-255
11 p.
|
artikel
|
| 4 |
Immunology and immunotherapy of neuroblastoma
|
Seeger, Robert C.
|
|
2011
|
21 |
4 |
p. 229-237
9 p.
|
artikel
|
| 5 |
MicroRNA and DNA methylation alterations mediating retinoic acid induced neuroblastoma cell differentiation
|
Stallings, Raymond L.
|
|
2011
|
21 |
4 |
p. 283-290
8 p.
|
artikel
|
| 6 |
Neuroblastoma aggressiveness in relation to sympathetic neuronal differentiation stage
|
Mohlin, Sofie A.
|
|
2011
|
21 |
4 |
p. 276-282
7 p.
|
artikel
|
| 7 |
Neuroblastoma genetics and phenotype: A tale of heterogeneity
|
Speleman, Frank
|
|
2011
|
21 |
4 |
p. 238-244
7 p.
|
artikel
|
| 8 |
Neuroblastoma research progress – A 2011 perspective
|
Henriksson, Marie Arsenian
|
|
2011
|
21 |
4 |
p. 215-216
2 p.
|
artikel
|
| 9 |
Progress in treatment and risk stratification of neuroblastoma: Impact on future clinical and basic research
|
Øra, Ingrid
|
|
2011
|
21 |
4 |
p. 217-228
12 p.
|
artikel
|
| 10 |
The MYCN oncogene and differentiation in neuroblastoma
|
Westermark, Ulrica K.
|
|
2011
|
21 |
4 |
p. 256-266
11 p.
|
artikel
|
Tijdschrift beschrijving